BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 892934)

  • 1. Enhancing lymphocytes in spleens of tumor-bearing mice: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    Int J Cancer; 1977 Aug; 20(2):239-46. PubMed ID: 892934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of suppressor lymphocytes during sensitization in culture against a syngeneic tumor: affinity chromatography on insolubilized histamine.
    Schechter B; Segal S; Feldman M
    J Immunol; 1978 Apr; 120(4):1268-73. PubMed ID: 641348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressor cells prevent host resistance to tumor growth.
    Schechter B; Feldman M
    Naturwissenschaften; 1979 Mar; 66(3):140-6. PubMed ID: 311899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor factor secreted by T-lymphocytes from tumor-bearing mice.
    Treves AJ; Cohen IR; Feldman M
    J Natl Cancer Inst; 1976 Aug; 57(2):409-14. PubMed ID: 1087347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific cytotoxicity in vitro of lymphocytes sensitized in culture against tumor cells.
    Schechter B; Treves AJ; Feldman M
    J Natl Cancer Inst; 1976 May; 56(5):975-9. PubMed ID: 994207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunoregulatory factor associated with spleen cells from tumor-bearing animals. I. Effect on tumor growth and antibody production.
    Isakov N; Segal S; Hollander N; Feldman M
    Int J Cancer; 1978 Oct; 22(4):465-70. PubMed ID: 359490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of suppressor cell activity by hydrocortisone: suppression of in vitro activation of splenocytes from mice bearing Lewis lung carcinoma.
    Clerici E; Schechter B; Feldman M
    Int J Cancer; 1980 Mar; 25(3):349-54. PubMed ID: 6446525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in cell surface antigens of tumor metastases and those of the local tumor.
    Fogel M; Gorelik E; Segal S; Feldman M
    J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor.
    Small M; Trainin N
    Int J Cancer; 1975 Jun; 15(6):962-72. PubMed ID: 1150350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fractionation of lymphocytes involved in the generation of cell-mediated cytotoxicity over insolubilized conjugated histamine columns.
    Shearer GM; Simpson E; Weinstein Y; Melmon KL
    J Immunol; 1977 Mar; 118(3):756-61. PubMed ID: 300387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
    Olsson L; Kiger N; Kronstrom H
    Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
    Fujii T; Igarashi T; Kishimoto S
    J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of mitogen responses and graft-versus-host reaction by splenocytes from mice bearing Lewis lung carcinoma.
    Anaclerio A; Moras ML; Conti G; Mistrello G; Spreafico F
    J Natl Cancer Inst; 1978 Aug; 61(2):471-5. PubMed ID: 28421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrocortisone affects tumor growth by eliminating precursors of suppressor cells.
    Schechter B; Feldman M
    J Immunol; 1977 Nov; 119(5):1563-8. PubMed ID: 915269
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro retrieval of the cytotoxic potential of spleen cells of tumor-bearing mice.
    Schechter B; Feldman M
    Isr J Med Sci; 1978 Jan; 14(1):131-45. PubMed ID: 632079
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A syngeneic metastatic tumor model in mice: the natural immune response of the host and its manipulation.
    Treves AJ; Cohen IR; Feldman M
    Isr J Med Sci; 1976; 12(4-5):369-84. PubMed ID: 1084880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Lewis lung carcinoma growth by sera or spleen cells from tumour-bearing mice.
    Fray A; Thobie N; Liacopoulos P
    Ann Immunol (Paris); 1982; 133C(3):289-98. PubMed ID: 7149644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal tissue alloantigens and genetic control of susceptibility to tumors: microcytotoxicity studies on resistant C3Hf and susceptible (A X C3Hf) F1 mice inoculated with transplacentally induced C3Hf lung tumor.
    Martin WJ; Esber E; Cotton WG; Rice JM
    J Immunol; 1975 Jul; 115(1):289-295. PubMed ID: 50354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.